human amniotic epithelial cells transplantation
Showing 1 - 25 of >10,000
Primary Ovarian Insufficiency, Premature Ovarian Failure, Infertility Trial in Shanghai (human amniotic epithelial cells (hAECs)
Recruiting
- Primary Ovarian Insufficiency
- +2 more
- human amniotic epithelial cells (hAECs) transplantation
-
Shanghai, Shanghai, ChinaThe International Peace Maternity and Child Health Hospital
Dec 15, 2021
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
Parkinson's Disease Trial in Shanghai (hAESCs treatment, (saline))
Not yet recruiting
- Parkinson's Disease
- hAESCs treatment
- placebo (saline)
-
Shanghai, Shanghai, ChinaJingwen Wu
Jun 23, 2022
Acute-graft-versus-host Disease Trial in Beijing (hAECs)
Recruiting
- Acute-graft-versus-host Disease
- hAECs
-
Beijing, Beijing, China
- +1 more
Sep 30, 2020
Chronic Kidney Diseases, Calciphylaxis, Calcific Uremic Arteriolopathy Trial in Nanjing (Human amniotic mesenchymal stem cells)
Active, not recruiting
- Chronic Kidney Diseases
- +3 more
- Human amniotic mesenchymal stem cells
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University, Jia
Aug 6, 2022
Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)
Completed
- Corneal Epithelial Defect
- Amniotic membrane transplantation
- Autologous serum/BSS 20%
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Nov 21, 2021
Production of iPSC Derived RPE Cells for Transplantation in AMD
Completed
- Age Related Macular Degeneration (AMD)
- (no location specified)
Apr 4, 2022
Diabetes, Type 1 Trial in Chicago (Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells)
Recruiting
- Diabetes Mellitus, Type 1
- Allogenic islet cells (human, U. Chicago)
- Intraportal infusion of islet cells
-
Chicago, IllinoisThe University of Chicago
Nov 7, 2022
The Innervation of Human Gut Sensory Epithelial Cells
Active, not recruiting
- Organoids
-
Durham, North CarolinaDuke Medical Center
Jan 11, 2022
Limbal Stem Cell Deficiency Trial in Boston (Biopsy to collect limbal epithelial stem cells that will be cultivated into a
Active, not recruiting
- Limbal Stem Cell Deficiency
- Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft
- +2 more
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Mar 21, 2022
Venous Leg Ulcer Trial in Chongqing (stem cell preparation combined with silver ion dressing, silver ion dressing)
Recruiting
- Venous Leg Ulcer
- stem cell preparation combined with silver ion dressing
- silver ion dressing
-
Chongqing, Chongqing, ChinaSouthwest Hospital, Army Medical University (Third Military Medi
Nov 30, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human
Completed
- Mucopolysaccharidosis I
- +15 more
- Human Placental Derived Stem Cell
-
Denver, Colorado
- +2 more
Oct 24, 2022
Diabetes, Type 1 Trial in Duarte (Allogenic Human Islet Cells, Gastrin 17)
Recruiting
- Diabetes Mellitus, Type 1
- Allogenic Human Islet Cells
- Gastrin 17
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 16, 2022
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)
Not yet recruiting
- Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
- ARTEGENE drug product
-
Paris, FranceDepartment of Pediatric Immunology, Hematology and Rheumatology
Sep 26, 2022
Diminished Ovarian Response Trial in Nanjing (stem cells)
Not yet recruiting
- Diminished Ovarian Response
- stem cells
-
Nanjing, Jiangsu, ChinaClinical Center of Reproductive Medicine at the First Affiliated
Feb 6, 2021
DNA Damage Trial in Split (Flouride in mouthrinses, Placebo mouthrinse)
Recruiting
- DNA Damage
- Flouride in mouthrinses
- Placebo mouthrinse
-
Split, CroatiaUniversity of Split School of medicine
Jan 27, 2022
Medication Related Osteonecrosis of the Jaw, Oral Surgery Trial in Edirne (HAM)
Active, not recruiting
- Medication Related Osteonecrosis of the Jaw
- Oral Surgery
- HAM
-
Edirne, Merkez, TurkeyTrakya University
Dec 28, 2021
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Stargardt's Macular Dystrophy Trial in Edinburgh, London, Newcastle upon Tyne (MA09-hRPE)
Completed
- Stargardt's Macular Dystrophy
- MA09-hRPE
-
Edinburgh, United Kingdom
- +2 more
Jul 4, 2021
Intrauterine Adhesion Trial in Hangzhou (hAESCs)
Recruiting
- Intrauterine Adhesion
- hAESCs
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Oct 25, 2020
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)
Recruiting
- Pancreatic Cancer
- Serous Ovarian Cancer
- VCN-01
- huCART-meso Cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 17, 2022
Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)
Recruiting
- Living Donor Kidney Transplantation
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
-
Palo Alto, California
- +1 more
May 6, 2022
Premature Ovarian Insufficiency Trial in Nanjing (transplantation of human UC-MSCs into ovaries of POI patients, hormone
Recruiting
- Premature Ovarian Insufficiency
- transplantation of human UC-MSCs into ovaries of POI patients
- hormone replacement treatment
-
Nanjing, Jiangsu, ChinaReproductive Medicine Center, The affiliated Drum Towel Hospital
Mar 25, 2022
Progressive Multiple Sclerosis Trial in Milan (human fetal-derived Neural Stem Cells (hNSCs))
Completed
- Progressive Multiple Sclerosis
- human fetal-derived Neural Stem Cells (hNSCs)
-
Milan, MI, ItalyIRCCS Ospedale San Raffaele
Sep 2, 2021